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Abstract: During a heart failure, an increased content and activity of nucleoside diphosphate kinase
(NDPK) in the sarcolemmal membrane is responsible for suppressing the formation of the second
messenger cyclic adenosine monophosphate (cAMP)—a key component required for calcium ion
homeostasis for the proper systolic and diastolic functions. Typically, this increased NDPK content lets
the surplus NDPK react with a mutated G protein in the beta-adrenergic signal transduction pathway,
thereby inhibiting cAMP synthesis. Thus, it is thus that inhibition of NDPK may cause a substantial
increase in adenylate cyclase activity, which in turn may be a potential therapy for end-stage heart
failure patients. However, there is little information available about the molecular events at the
interface of NDPK and any prospective molecule that may potentially influence its reactive site
(His118). Here we report a novel computational approach for understanding the interactions between
graphene oxide (GO) and NDPK. Using molecular dynamics, it is found that GO interacts favorably
with the His118 residue of NDPK to potentially prevent its binding with adenosine triphosphate
(ATP), which otherwise would trigger the phosphorylation of the mutated G protein. Therefore,
this will result in an increase in cAMP levels during heart failure.
Keywords: nucleoside diphosphate kinase; graphene oxide; molecular dynamics; heart failure
1. Introduction
The American Heart Association reports that the predicted population diagnosed with heart
failure will rise to 46% by 2030 [1]. The most prevalent feature of a failing heart is when the systolic
and/or diastolic functions are curtailed due to an imbalance in intracellular calcium ion (Ca2+)
homeostasis in cardiomyocytes. In a non-failing heart, a cardiac contraction is initiated when an
inflow of Ca2+ is released through L-type Ca2+ channels. This external influx prompts a large amount
of Ca2+ from the internal stores in the cardiac sarcoplasmic reticulum to be released into the sarcoplasm.
Subsequently, the calcium ions that are pumped out interact with the contractile proteins that use ATP
to contract the muscle fiber, a process known as excitation-contraction coupling, where an electrical
stimulus is converted into a mechanical response. An essential component for the maintenance
of intracellular Ca2+ homeostasis is the diffusible intracellular second messenger cyclic adenosine
monophosphate (cAMP): a product of the beta-adrenergic pathway that activates protein kinase A
(PKA), which is, in turn, an enzyme dependent on cAMP activity and concentration [2]. PKA activates
the Ca2+ channels and many other components of the cardiac excitation-contraction process [3].
A key player in the beta-adrenergic pathway needed for cAMP production is nucleoside
diphosphate kinase (NDPK): a ubiquitous enzyme that plays a plethora of roles in the body such as
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phosphorylation, regulating various types of membrane enclosures that absorb dying cells during
development, and regulating metastasis through its ability to take in bacteria or micronutrients [4,5].
It is now known that NDPK is found in the hearts of many species and is a key player in heart
failure [6].
NDPK is responsible for transferring a phosphate group from ATP to GDP, and this process
is illustrated in Figure 1a. More specifically, the beta-gamma dimer binds to NDPK and receives a
phosphate from NDPK’s active residue His118, onto its own residue His-266 [7]. Figure 1d shows the
structure of NDPK and the location of the histidine residue.
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Figure 1. (a) The role of nucleoside diphosphate kinase (NDPK) in a non-failing heart. Typically, Gβγ
binds with Gα and this guanosine diphosphate (GDP(s)) as a whole is further converted to Guanosine
-5′-Triphosphate (GTP(s)) with the help of NDPK that triggers the adenylate cyclase in a depende t
pat way to synthesize the cAMP; (b) R le of NDPK in a failing heart. During heart f ilure, the same
NDPK inhibits the adenylate cyclase activity due to its increased interaction with cAMP inhibitory
membrane proteins in the form of GDP(i), which is the result of the binding between Gβγ and Gα(i),
and the eventual conversion of GDP(i) to GTP(i); (c) Potential effects that may result due to graphene
oxide inhibiting NDPK. The inhibition of NDPK by graphene oxide during heart failure can prevent
the suppression of cAMP formation through the dependent pathway. Adenylate cyclase activity is
resumed because the NDPK molecules reacting with Gi proteins are inhibited and the faulty GTP(i)
is not formed anymore. The NDPK independent pathways continue to produce cAMP without the
suppression that was occurring due to NDPK molecules reacting with the Gi proteins; (d) The structure
of NDPK and the active sites on each monomer. Monomer are defined by labels: P1, P2, P3, P4 in
Visual Molecular Dynamics (VMD)—a molecular graphics program. (Figures a–c are modified from
Source: Biochemistry, Sixth Edition © 2007 W.H Freeman and Company).
Adren rgic recepto s are comprised of G proteins that co tain alpha, beta, and gamma subunits [8].
G proteins are heterotrimeric proteins containing 3 subunits and having their own family of proteins [9].
The alpha subunit attached to the beta-adrenergic receptor is called the Gs Alpha subunit. This subunit
is responsible for stimulating the cAMP-dependent pathway by binding to the NDPK and thereby
contributing to the activation of adenylate cyclase [10]. During end-stage heart failure, however,
there is a 300% increase in NDPK content in the cardiac sarcolemmal membrane [7]. Normally,
this overexpression of NDPK would cause an abundance of cAMP molecules. However, there is
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also a drastic increase in the levels of catecholamine, which affects the signaling of G proteins [11].
Therefore, this increase in the NDPK, in addition to an increase in Gi alpha subunits, results in the
NDPK molecules reacting predominantly with the Gi (GDP(i)) inhibitory proteins in a dependent
pathway. This is then responsible for inhibiting cAMP [12,13]. A direct consequence of this pathway
is expressed in Figure 1b, indicating that the Guanosine-5′-Triphosphate (GTP) formed through
NDPK phosphorylation during heart failure is responsible for inhibiting adenylate cyclase activity
and restricting the conversion of ATP to cAMP to PKA. However, from past research, it has been
shown experimentally that inhibition of NDPK in failing hearts causes a substantial increase in
adenylate cyclase activity [14]. Furthermore, G protein pathways can be receptor-dependent or
receptor-independent. The pathways indicated by Figure 1a,b represent receptor-dependent pathways
because the cascade of reactions take place only when a ligand binds onto the receptor. However,
receptor-independent pathways are also able to generate cAMP with only guanosine diphosphate
(GDP) and adenosine triphosphate (ATP). One such study showed that when uracil diphosphate (UDP)
was used to inhibit transphosphorylation in a healthy heart, stimulation of cardiac adenylate cyclase
by GTP increased. The result was no change in the adenylate cyclase activity, indicating that such
an independent pathway doesn’t involve NDPK. Figure 1c shows that if NDPK activity is restricted
during heart failure, the inhibitory effects of NDPK can be hindered, and the receptor-independent
pathway can continue to produce cAMP [15]. Research has shown that inhibiting NDPK results in
favorable outcomes [16]. In order to test a potential solution, whereby blocking the active NDPK site
may be beneficial in case of heart failure, this work analyzed the interactions between an oxidized
carbon allotrope, graphene oxide (GO) and NDPK owing to interests in GO in biotechnology and
biomedical fields. Nanomaterials like carbon nanotubes have been shown not inducing cell death.
Therefore, they have relatively low toxicity [17]. More specifically, GO has been shown to be potentially
applied in gene and drug delivery, cancer therapeutics, cellular imaging, as an antibacterial agent
and bio-sensing [18–22]. Furthermore, GO is an ideal enzymatic substrate because it is saturated
with oxygen-containing groups, allowing it to interact with enzymes without modification of the
surface [23]. Additionally, GO is also a model substrate because it is biocompatible, has a large surface
area, hydrophilic nature and has excellent colloidal stability in water [24,25]. This is the first report
of the computational understanding of the interactions of NDPK in general and the phosphorylation
site (histidine118) on the NDPK in particular with GO substrate. An all atom molecular dynamics
simulation approach is utilized to quantify the interactive events at the interface of GO and NDPK
towards potential applications for new therapies in case of heart failure.
2. Results and Discussion
To study the molecular events taking place at the interface of GO and NDPK, the simulated
trajectory from the all-atom simulations of 100 ns was utilized. Through the molecular graphics
program, VMD, the behavior of NDPK atoms with respect to GO was studied as shown in Figure 2 at
different times during the 100 ns period. It can be seen from Figure 2 that the GO flake closest to the
NDPK segments P1 and P3 directly interacted with the reactive site of NDPK (His118) after scanning
the surface of NDPK for ~60 ns to locate a favorable conformation of the enzyme. The rest of the
GO flakes showed attraction to the NDPK as well, but were not able to bind to the enzyme like GO5.
The implications of these interactive events directly relate to the phosphorylation ability of NDPK
indicating that NDPK can be constrained from binding to ATP for the exchange.
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are shown relative to the positions of the His118 residue and the NDPK enzyme. It can be seen that
by 50 ns, graphene oxide starts interacting with the His118 residue and by 100 ns, graphene oxide
completely blocks His118 residue’s interaction with the environment. NDPK is represented as a cartoon
with a coloring style based on individual residues and His118 and graphene oxide are shown in the
CPK representation showing the oxygen and hydrogen functionalities in red and white with carbon in
cyan respectively.
In order to investigate further and explore the energies and biophysical phenomena accompanying
such an interaction, VMD’s Analyses Plugins were utilized for studying the root mean square deviation
(RMSD), non-binding energies such as Van der Waals and electrostatic (summation of both being the
interaction energy), conformational energies for bonds, angles and dihedrals and the effect of such an
interaction on the secondary structure of NDPK. RMSD is the deviation from the initial position of each
component in the simulation. Figure 3a reveals that at ~60 ns from the beginning of the simulation
run, NDPK stabilizes to a new conformation in the presence of GO. It is to be noted that the stability
of both GO and NDPK at the threshold of binding is ~1 Å, which can be treated as a very stable and
sustained complex formation. Interestingly, the RMSD of His118 also showed a stable behavior within
2 Å of the GO surface (Figure 3b).
Interaction energy is the summation of electrostatic attractions and the van der Waals forces
between molecules, which is an atom-to-atom interaction and its integration over the entire adsorbed
surface. Segments P1 and P3 were also analyzed for the total interaction energy and as can be seen
from Figure 3c, maximum sustained interaction energy levels of ~85 kcal/mol between GO and NDPK
were noticed after the 60 ns threshold that involved the 37 residues (Table 1) bound onto the surface of
GO. Based on the number of residues bound, on an average the interaction energy per residue should
be ~2.3 kcal/mol. However, looking at Figure 3d, it is found that His118 alone binds with three times
this value (~6 kcal/mol by the end of the 100 ns run) clearly demonstrating the affinity of His118 to
GO and hence gives a crucial insight into a potential therapy towards sustained cAMP synthesis in
case of heart failure. Both the Root Mean Square Fluctuation (RMSF) and secondary structure analysis
verify this affinity of His118 to the GO (Supplementary Figures S2 and S3). It is found that the RMSF
of the His118 in the absence of GO (Figure S2A) is ~0.3 Å whereas in the presence of GO (Figure S2B),
it varies from 0.445 to 3.134 Å indicating the molecular rearrangement in this key residue to find a
favorable adsorption orientation on the surface of GO. Similarly, comparing the secondary structure of
NDPK in the presence of GO (Figure S1) and in the absence of GO (Figure S3), it can be seen that the
key residue His118 doesn’t lose its vital conformation as a part of the extended beta structure while
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interacting with the GO. This analysis based on the RMSD and the interaction energy calculations
determined both strength and stability of the attractive forces between the enzyme and GO. It is to be
noted that only the residues within 5 Å from the GO surface are considered to be directly influencing
the process to be realistic in terms of the dominating short-range forces and most of these residues
have a hydrophobic side chain.
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Figure 3. (a,b) show the Root Mean Square Deviation (RMSD) of the two middle NDPK monomers,
graphene oxide (GO) flakes and the histidine residue 118 throughout the 100 ns simulation. Segment
names P1 and P3 refer to the two middle monomers of the NDPK enzyme defined earlier in Figure 1d;
(c) Interaction Energy between GO and the two middle NDPK monomer segments P1 and P3;
(d) Interaction energy between GO and His118 residue.
Table 1. Residues within 5 Angstrom of Graphene Oxide Surface.
Residue Name Residue ID Residue Type
Histidine 122, 118 Basic, positively charged
Aspartic Acid 57, 124, 148, 14, 121 Acidic, negatively charged
Glutamic Acid 123, 125 Acidic, neg vely charged
Tryptophan 1 4, 51 Aromatic, hydrophobic
Leucine 152, 64, 112 Aliphatic, hydrophobic
Tyrosine 153, 52 Aromatic, hydrophobic
Methionine 10 Sulfur-containing, hydrophobic
Lysine 12, 58 Basic, positively charged
Glycine 126, 63, 71, 113, 119 Aliphatic, hydrophobic
Proline 13, 59, 72 Aliphatic
Glutamine 42 Amidic, polar uncharged
Isoleucine 43, 68 Aliphatic, hydrophobic
Threonine 69 Hydrophilic, polar uncharged
Valine 73 Aliphatic, hydrophobic
Asparagine 115 Amidic, polar uncharged
Phenylalanine 60, 67 Aro atic, hydrophobic
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The interaction energy, which is largely due to the Van der Waals forces in the present case is
directly related to the surface area of the enzyme interacting with GO. Thus, in order to understand
the role of the 18 hydrophobic residues with 5 Å of GO, relative cut-off distances between the center
of mass of GO and the center of mass of the hydrophobic residues, and the associated interaction
energies were analyzed (Figure 4). Interestingly, it was discovered that the optimum cut-off distance for
maximum interaction energy per atom is ~3.75 Å. As can be seen from Figure 4a,b, the number of atoms
and interaction energy because of these atoms were calculated relative to the cut-off distances from 1
to 12 Å. Figure 4c shows the optimum cut-off distance by determining the ratio of the number of atoms
to the associated interaction energies. Furthermore, minor conformation changes to accommodate the
interactions is visible from Figure 4d, which shows the total conformation energy shifting its average
value ~60 ns in the simulation run coinciding with the threshold of complex formation between GO
and NDPK as NDPK finds a favorable location on the surface of GO. These minor conformational
changes are expected and the retaining of the conformational energy to a new value also confirms the
stable conformation of the enzyme.
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Figure 4. (a) The average number of atoms of the enzyme that are located from the respective cutoff
distances from the graphene oxide flake; (b) The interaction energy between the enzyme and the
graphene oxide as a function of the cutoff distance; (c) The interaction energy divided by the number
of atoms as a function of the cut-off distance; (d) The conformational energies throughout the 100 ns.
In order to compare the energies of binding between the 18 hydrophobic residues and the rest of
the residues within 5 Å from the surface of GO, two separate interaction energy profiles are generated.
Figure 5a,b shows the difference in the interaction energies due to the 17 hydrophobic residues and
rest of the 37 bound residues of NDPK. It can be seen that the interaction energy between GO and the
hydrophobic residues reach levels of upto −60 kcal/mol and that the interaction energy between GO
and the non-hydrophobic residues reach levels of ~−40 kcal/mol. This shows that GO has greater
affinity for the hydrophobic residues.
Figure 5c shows the change in the distance between the center of mass of GO and the center of
mass of His118 indicating the affinity of His118 to GO, where His118 moved from a distance of ~25 Å
down to less than 5 Å in about 60 ns. This rapid reduction in the distance between the two also is
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indicative of strong Van der Waals attractions and a crucial role that the 17 hydrophobic residues
played in binding with GO.
The radius of gyration is a measure of the compactness of a protein. With the introduction of
graphene-oxide, the radius of gyration remains the same. Figure 5d is a log-log plot of Rg in the
presence and absence of GO. It signifies that NDPK has not lost its complete conformation with the
introduction of GO. However, the strong binding of GO with NDPK makes GO an inhibitor of the
enzyme, without compromising its 3D arrangement owing to a little difference between the Rg values
of NDPK in the presence and absence of GO.
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Solvent Accessible Surface Area (SASA) (nm2) Presence of GO Absence of GO 
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Segment P2 97.80 (66.7, 111) 83.65 (22.83, 60.81) 
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Figure 5. (a) The interaction energy betw en graphene oxide and the hydrophobic residues listed in
Table 3; (b) The interaction energy betw en graphene oxide and the non-hydrophobic residues listed
in Table 3; (c) The distance in angstroms betw en the center of ma s of the graphene oxide and the
primary residue; (d) Radius of gyration of NDPK in the presence and absence of .
Table 2 displays the Solvent Accessible Surface Area (SASA) for regions in the enzyme in the
presence and absence of GO. In its native state, in the absence of GO, 286 nm2 of NDPK’s surface area is
accessible to water. But, as GO is introduced near its active site, the amino-acids rearrange themselves
resulting in a higher exposure of the protein to water as indicated by an increased SASA value of
~329 nm2. In the absence of GO, 45.24% of the NDPK’s hydrophobic residues are exposed to the
solvent (water) but as GO is lodged in the active site of the enzyme, the hydrophobic residues rearrange
themselves to interact strongly with GO as 24.31% of those residues are capable of interacting with
water. This is a 20.9% decrease from the former value. The hydrophobic regions of NDPK are bound to
GO, which is a good indicator of the inhibitory activity of GO as conserved domains (hydrophobic
in nature) are attributed to the primary function of most proteins. Table 2 also displays SASA for the
hydrophobic and hydrophilic regions of the individual segments in the parenthesis next to the values
for the whole segments.
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Table 2. Solvent Accessible Surface Area (SASA).
Solvent Accessible Surface Area (SASA) (nm2) Presence of GO Absence of GO
Segment P1 96.71 (68, 109.61) 89.40 (22.54, 66.85)
Segment P2 97.80 (66.7, 111) 83.65 (22.83, 60.81)
Segment P3 104.70 (68.58, 116.52) 87.35 (21.76, 65.6)
Segment P4 97.70 (65.95, 110.9) 84.25 (21.52, 62.72)
NDPK (whole) 328.80 286.19
Hydrophobic region of NDPK 243.80 65.13
Hydrophilic region of NDPK 426.95 221.06
Figure 6a is the Ramachandran plot in the absence of GO. The blue and green regions on the
plot indicate the favorable and allowed regions of conformation. In their native state, majority of the
amino-acid residues (indicated by the yellow squares) in NDPK have permissible Φ and Ψ values in
the favored and allowed regions when GO is absent. When GO is present with NDPK, as shown in
Figure 6b, there are no drastic differences observed in the state of NDPK indicating that the protein
does not lose its dominant alpha-helix structure but rearranges itself to interact strongly with GO at its
active site.
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Figure 6. Ramachandran Plot in the (a) absence and (b) presence of GO. Blue and green regions indicate
the favorable and allowed regions of conformation on the NDPK enzyme. Little yellow squares indicate
the individual amino acid residues. There are no drastic changes observed in the presence and absence
of GO indicating that NDPK doesn’t lose its function while strongly interacting with GO.
While this study is important from the point of view of therapeutics in case of failing hearts,
it is equally important to regulate the binding of GO with His118, thereby making sure that the
secondary structu e of the enzyme is tact and capable of performi g its function as a phosphorylation
intermediary in the event that GO is forced to unbind the reactive site. This led to the analysis of the
secondary structure of NDPK post binding (Figure S1) and it is found that although GO is able to
temporarily inhibit the function of NDPK, it does not damage the enzyme permanently. Together these
results indicate that GO favorably interacted with NDPK and potentially blocked the phosphorylation
site of NDPK.
3. Materials and Methods
The interactions between NDPK and GO were simulated using nanoscale molecular dynamics
(NAMD): a molecular dynamics code designed to simulate large biomolecular systems [26].
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The results from the simulation were analyzed using Visual Molecular Dynamics (VMD, University
of Illinois–Urbana, Urbana, IL, USA): a molecular visualization program that is used for displaying,
animating, and analyzing the systems that are simulated using NAMD. NAMD [27] and VMD [28]
were used together to simulate and analyze the interactions between NDPK and GO. The necessary
structural file for the NDPK was obtained from the pdb databank (2ZUA). The structural file for GO
was created using molefacture plugin in VMD from the graphene sheet generated using an inbuilt
graphene sheet builder plugin, which was then used to create six GO flakes (size 15.45 Å × 11.68 Å).
The chemical structure of the flakes used is C10O1(OH)1(COOH)0.5, also known as OGO [29]. The pdb
file of this structure was edited for the incorporation of the six GO flakes and their orientation through
the x,y,z co-ordinates around the NDPK molecule in the pdb file was modified using a TCL script in
the VMD. The flakes were placed so they were approximately equidistant from the active sites, namely
the His118 residue. Their respective distances from the four His118 active sites on the enzyme are
given in Table 3.
Table 3. Initial positioning of the GO flakes.
GO Flake Active Site Location Approximate Distance from Active Site (Angstroms)
GO1 P4 35.94
GO2 P4 31.61
GO3 P2 34.24
GO4 P2 28.85
GO5 P3 32.83
GO6 P1 29.98
All-atom simulations were carried out between the six GO flakes and NDPK (~120,000 atoms) for
a time period of 100 ns. All simulations used CHARMM (Chemistry at HARvard Macromolecular
Mechanics) force field [30] with Transferable Intermolecular Potential with 3 Points (TIP3P) [31] water
model and neutralizing concentration of NaCl to effectively polarize the water molecules. The Extreme
Science and Engineering Discovery Environment (XSEDE) [32] supercomputing facility provided
access to 54 Central Processing Units (CPU) pairs with 28 cores per CPU (1512 cores) supercomputer
cluster on which simulations were carried out. The temperature was set to 300 K and maintained by
Langevin Thermostat, the pressure was set to 1 atm. Through Nose-Hoover Langevin-piston barostat
with a period of 100 ps and a decay rate of 50 ps. An integrated time-step of 2 fs was maintained for all
simulations. A cut-off of 10–12 Å was used for short-range forces which particle mesh Ewald algorithm
was used for calculating long-range forces. A 5000—step energy minimization was performed first on
the entire system (GO, NDPK, water and ions) to reach a minimum for the potential energy followed
by an equilibration of 500,000 steps (1 ns). Root Mean Square Deviation (RMSD) and NAMD Energy
extensions were used from VMD to determine the interaction energies between the NDPK and the GO
flakes. Additionally, TimeLine tool from VMD is utilized to analyze the secondary structure of the
NDPK while it interacts with the GO flakes. Interaction energies, optimum cut-off distances from the
surface of GO flakes and relative distance between the GO flakes and NDPK were quantified using
TCL scripts.
4. Conclusions
In conclusion, this study analyzed the events occurring at the interface of GO and NDPK from
the viewpoint of energetically favorable residues through molecular dynamics simulations. It is
found that owing to the interactions between GO and the potential phosphorylation site through
the residue histidine (118) on NDPK, cAMP synthesis can be regulated via the controlled blocking
of this residue. During heart failure, cAMP production is curtailed due to NDPK increasing the
activity of cAMP inhibitory pathways. The presence of NDPK in non-failing hearts increase the activity
of cAMP stimulatory pathways. Therefore, the inhibition of NDPK activity using GO is temporary.
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This study can be extended in a multitude of ways through experiments and a more complex interactive
analysis using only the major isoforms of NDPK (NDPK-B and NDPK-C) that are responsible for
the remodeling of the heart in the case of heart failure. Furthermore, this study can also be applied
to project interactive events of NDPK in general for other cellular processes and their regulation.
For example, because NDPK plays a role in cell proliferation, GO can potentially be used to inhibit the
undesired proliferation. Also, GO can be removed from the enzyme by inserting a stronger substrate
that can take the place of GO by creating a competitive environment. Since the simulation showed that
the residues of NDPK retained its secondary structure after interaction with GO, a “switch” can be
established where NDPK can be disabled and enabled based on the circumstance. It is anticipated that
inhibiting NDPK during heart failure will prevent cAMP production from being suppressed, which
will help maintain cardiomyocyte Ca2+ homeostasis for proper cardiac contraction for a sustained
periods of time, which can be beneficial for developing new therapies.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4991/8/2/57/s1,
Figure S1: Secondary structure timeline analysis computed by VMD’s timeline plug-in, Figure S2: Root Mean
Square Fluctuation (RMSF) of the His118 residue from the four monomers, P1, P2, P3 and P4 in the absence
(A) and presence (B) of graphene oxide; Figure S3: Secondary structure analysis of the NDPK enzyme in the
absence of graphene oxide showing the His118 residue from the four monomers P1, P2, P3 and P4 undergoing
conformational changes.
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